Editas Medicine

(NASDAQ) EDIT

Current Price$3.04

Market Cap$310.74M

Since IPO (2016)-83%

5 Year-91%

1 Year+139%

1 Month+17%

Editas Medicine Financials at a Glance

Market Cap

$310.74M

Revenue (TTM)

$35.86M

Net Income (TTM)

$108.95M

EPS (TTM)

$-1.88

P/E Ratio

-2.60

Dividend

$0.00

Beta (Volatility)

2.09 (High)

Dividend

$0.00

Beta (Volatility)

2.09 (High)

Price

$3.04

Volume

77,985

Open

$3.25

Price

$3.04

Volume

77,985

Open

$3.25

Previous Close

$3.04

Daily Range

$2.98 - $3.25

52-Week Range

$1.29 - $4.54

Dividend

$0.00

Beta (Volatility)

2.09 (High)

Price

$3.04

Volume

77,985

Open

$3.25

Previous Close

$3.04

Daily Range

$2.98 - $3.25

52-Week Range

$1.29 - $4.54

EDIT News

Page 1

EDIT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Editas Medicine

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Gilmore O’Neill, MD

Website

www.editasmedicine.com

Headquarters

Cambridge, MA 02141, US

EDIT Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

-198%

Return on Capital

-82%

Return on Assets

-73%

Earnings Yield

-38.46%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$310.74M

Shares Outstanding

97.87M

Volume

77.98K

Avg. Volume

1.61M

Financials (TTM)

Gross Profit

$40.52M

Operating Income

$99.34M

EBITDA

$148.61M

Operating Cash Flow

$165.24M

Capital Expenditure

$607.00K

Free Cash Flow

$165.85M

Cash & ST Invst.

$146.65M

Total Debt

$76.71M

Editas Medicine Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$310.74M

N/A

Market Cap/Employee

$1.26M

N/A

Employees

246

N/A

Net Income

$24.98M

+67.2%

EBITDA

$0.00

+100.0%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$106.35M

-44.0%

Accounts Receivable

$2.59M

+408.2%

Inventory

$0.00

N/A

Long Term Debt

$10.60M

-41.0%

Short Term Debt

$6.70M

-49.1%

Return on Assets

-72.96%

N/A

Return on Invested Capital

-82.25%

N/A

Free Cash Flow

$23.15M

+51.7%

Operating Cash Flow

$23.06M

+51.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VNDAVanda Pharmaceuticals Inc.

VNDAVanda Pharmaceuticals Inc.$6.39-14.11%

VYGRVoyager Therapeutics, Inc.

VYGRVoyager Therapeutics, Inc.$3.96-5.04%

CABACabaletta Bio, Inc.

CABACabaletta Bio, Inc.$4.00+7.24%

KYTXKyverna Therapeutics, Inc.

KYTXKyverna Therapeutics, Inc.$9.30-1.80%

AVIRAtea Pharmaceuticals, Inc.

AVIRAtea Pharmaceuticals, Inc.$5.54-1.95%

PRQRProQR Therapeutics N.V.

PRQRProQR Therapeutics N.V.$1.58-8.14%

LYELLyell Immunopharma, Inc.

LYELLyell Immunopharma, Inc.$20.06-3.79%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.47+0.07%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.34-0.00%

SNAPSnap

SNAPSnap$5.98-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.18+0.02%

ATRAAtara Biotherapeutics

ATRAAtara Biotherapeutics$9.93+0.93%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$45.73+0.00%

ONDSOndas

ONDSOndas$8.89-0.05%

Questions About EDIT

What is the current price of Editas Medicine?

Editas Medicine is trading at $3.04 per share.

What is the 52-week range for Editas Medicine?

Over the past 52 weeks, Editas Medicine has traded between $1.29 and $4.54.

How much debt does Editas Medicine have?

As of the most recent reporting period, Editas Medicine reported total debt of $71.97M.

How much cash does Editas Medicine have on hand?

Editas Medicine reported $123.65M in cash and cash equivalents in its most recent financial results.

What is Editas Medicine’s dividend yield?

Editas Medicine does not currently have a dividend yield.

Editas Medicine

Editas Medicine Financials at a Glance

EDIT News

Is Editas Medicine Going to $0?

Why Editas Medicine Stock Was Skyrocketing This Week

Can This Beaten-Down Stock Bounce Back?

Wall Street Expects Editas Medicine to Soar 53%. Is It Time to Buy Now?

2 Beaten-Down Stocks to Avoid

Editas Medicine Is Great. Here's Why You Shouldn't Buy It.

1 Stock Down 97% That Could Double, According to Wall Street

Editas Medicine: A Cautionary Tale for Investors

EDIT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Editas Medicine

EDIT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Editas Medicine Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About EDIT

What is the current price of Editas Medicine?

What is the 52-week range for Editas Medicine?

How much debt does Editas Medicine have?

How much cash does Editas Medicine have on hand?

What is Editas Medicine’s dividend yield?

Premium Investing Services